Women with certain cardiometabolic risk factors face a disproportionately greater increase in the odds of clinically ...

A recent review highlights a promising therapeutic target for metabolic dysfunction–associated fatty liver disease (MAFLD) ...

A study reveals 26% of Type-2 diabetics have hidden liver fibrosis, urging early detection to prevent severe complications.

Please provide your email address to receive an email when new articles are posted on . Noninvasive tests for liver fibrosis screening performed worse among Black adults vs. other racial-ethnic groups ...

While fatty liver disease has been touted as the most common liver condition among diabetes patients, the new study ...

Researchers at UCLA Health uncovered new information about the role inflammation plays in mitigating liver fibrosis, which is associated with metabolic-associated fatty liver disease (MAFLD), one of ...

A significant number of people had asymptomatic liver disease, according to a large-scale European study. The LIVERSCREEN study is assessing a feasible, non-invasive screening strategy for liver ...

Fatty liver disease is when too much fat builds up in the liver. The liver is the body's filter. It helps clean the blood, ...